Ensuring rational introduction and responsible use of new TB tools: Outcome of an ERS multisector consultation

European Respiratory Journal

Volumn 44, Issue 6, 2014, Pages 1412-1417

  Migliori, Giovanni Battista ^a   Lienhardt, Christian ^b   Weyer, Karin ^b   Van Der Werf, Marieke J ^c   Blasi, Francesco ^d   Raviglione, Mario C ^b  

^a IRCCS   (Italy)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

QUINOLINE DERIVED ANTIINFECTIVE AGENT; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; BACTERIAL STRAIN; BACTERIUM CULTURE; CHROMOSOME MUTATION; CLINICAL EFFECTIVENESS; CONSENSUS DEVELOPMENT; CONSULTATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DISEASE SURVEILLANCE; DRUG APPROVAL; DRUG EFFICACY; DRUG INDICATION; DRUG INDUSTRY; DRUG RESEARCH; DRUG SURVEILLANCE PROGRAM; DRUG USE; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH PERSONNEL ATTITUDE; HEALTH PROGRAM; HEALTH PROMOTION; HUMAN; INAPPROPRIATE PRESCRIBING; INTERDISCIPLINARY COMMUNICATION; INTERDISCIPLINARY RESEARCH; LOWER RESPIRATORY TRACT INFECTION; MEDICAL ETHICS; MEDICAL SOCIETY; MEDICATION ERROR; MOLECULAR DIAGNOSTICS; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATIENT SAFETY; POINT OF CARE TESTING; PRACTICE GUIDELINE; PROTOCOL COMPLIANCE; PUBLIC HEALTH; PUBLIC HEALTH PROBLEM; PUBLIC HEALTH SERVICE; PUBLIC-PRIVATE PARTNERSHIP; REPRODUCIBILITY; REVIEW; RISK ASSESSMENT; SOCIAL NETWORK; STANDARDIZATION; STRATEGIC PLANNING; SYMPOSIUM; TREATMENT DURATION; TREATMENT RESPONSE; TUBERCULIN TEST; TUBERCULOSIS; TUBERCULOSIS CONTROL; TUBERCULOSIS RAPID TEST; WORLD HEALTH ORGANIZATION; EUROPE; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

ANTITUBERCULAR AGENTS; EUROPE; HEALTH POLICY; HUMANS; SOCIETIES, MEDICAL; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

EID: 84916210953     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00132114     Document Type: Review

References (35)

1. World Health Organization. Strategic and Technical Advisory Group for TB meets in Geneva. www.who.int/tb/features-archive/stag-2014/en Date last accessed: July 2, 2014. Date last updated: June 23, 2014.
2. Sotgiu G, Woodhead M. Good news about a bad subject: scientific evidence to help defeat multidrug/extensively drug-resistant tuberculosis. Eur Respir J 2014; 44: 5-7.
3. Tanimura T, Jaramillo E, Weil D, et al. Financial burden for tuberculosis patients in low-and middle-income countries: a systematic review. Eur Respir J 2014; 43: 1763-1775.
4. World Health Organization. Global Tuberculosis Report 2013. DocumentWHO/HTM/TB/2013.11. Geneva, WHO, 2013.
5. World Health Organization. Global strategy and targets for tuberculosis prevention, care and control after 2015. http://apps.who.int/gb/ebwha/pdf-files/EB134/B134-12-en.pdf?ua51 Date last accessed: July 2, 2014. Date last updated: November 29, 2013.
6. Diel R, Loddenkemper R, Zellweger JP, et al. Old ideas to innovate tuberculosis control: preventive treatment to achieve elimination. Eur Respir J 2013; 42: 785-801.
7. D'Ambrosio L, Dara M, Tadolini M, et al. Tuberculosis elimination: theory and practice in Europe. Eur Respir J 2014; 43: 1410-1420.
8. Voniatis C, Migliori GB, Voniatis M, et al. Tuberculosis elimination: dream or reality? The case of Cyprus. Eur Respir J 2014; 44: 543-546.
9. European Centre for Disease Prevention and Control. Framework action plan to fight tuberculosis in the European, Union. Stockholm, ECDC, 2008.
10. Weyer K, Mirzayev F, Migliori GB, et al. Rapid molecular TB diagnosis: evidence, policy making and global implementation of Xpert MTB/RIF. Eur Respir J 2013; 42: 252-271.
11. UNITAID.Tuberculosis Diagnostic Technology and Market Landscape: Semi-annual update. 2013. www.unitaid.eu/images/marketdynamics/publications/UNITAID-TB-Dx-Landscape-Update-Dec%202013.pdf Date last accessed: July 2, 2014. Date last updated: December 2013.
12. UNITAID.Tuberculosis Medicines Technology and Market Landscape: 1st edition. 2013. www.unitaid.eu/images/marketdynamics/publications/UNITAID-TB-Medicines-Landscape-1st-edition.pdf Date last accessed: July 2, 2014. Date last accessed: September 2013.
13. Raviglione MC, Lange C, Migliori GB. Preventing and managing antimicrobial resistance: imperative for chest physicians. Eur Respir J 2011; 37: 978-981.
14. Leung E, Weil DE, Raviglione M, et al. The WHO policy package to combat antimicrobial resistance. Bull World Health Organ 2011; 89: 390-392.
15. World Health Organization. The use of bedaquiline in the treatment of multidrug-resistant tuberculosis: interim policy guidance. Document WHO/HTM/TB/2013.6. Geneva, WHO, 2013.
16. Colijn C, Cohen T, Ganesh A, et al. Spontaneous emergence of multiple drug resistance in tuberculosis before and during therapy. PLoS ONE 2011; 6: e18327.
17. Van der Werf MJ, Langendam MW, Huitric E, et al. Multidrug resistance after inappropriate tuberculosis treatment: a meta-analysis. Eur Respir J 2012; 39: 1511-1519.
18. Matthys F, Rigouts L, Sizaire V, et al. Outcomes after chemotherapy with WHO category II regimen in a population with high prevalence of drug resistant tuberculosis. PLoS One 2009; 4: e7954.
19. Cox HS, Niemann S, Ismailov G, et al. Risk of acquired drug resistance during short-course directly observed treatment of tuberculosis in an area with high levels of drug resistance. Clin Infect Dis 2007; 44: 1421-1427.
20. Langendam MW, van der Werf MJ, Huitric E, et al. Prevalence of inappropriate tuberculosis treatment regimens: a systematic review. Eur Respir J 2012; 39: 1012-1020.
21. Migliori GB, Langendam MW, D'Ambrosio L, et al. Protecting the tuberculosis drug pipeline: stating the case for the rational use of fluoroquinolones. Eur Respir J 2012; 40: 814-822.
22. World Health Organization. Treatment of tuberculosis: guidelines for national programmes. Fourth Edition. Document WHO/HTM/TB/2009.420. Geneva, WHO, 2010.
23. Falzon D, Jaramillo E, Schünemann HJ, et al. WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. Eur Respir J 2011; 38: 516-528.
24. World Health Organization. Introduction and rational use of new drugs/regimens for the treatment of tuberculosis in countries. www.who.int/tb/new-drugs/en/Date last accessed: July 2, 2014.
25. TB CARE I. International Standards for Tuberculosis Care, Edition 3. The Hague, TB CARE I, 2014.
26. Migliori GB, Zellweger JP, Abubakar I, et al. European union standards for tuberculosis care. Eur Respir J 2012; 39: 807-819.
27. Van der Werf MJ, Sandgren A, D'Ambrosio L, et al. The European Union standards for tuberculosis care: do they need an update? Eur Respir J 2014; 43: 933-942.
28. Sotgiu G, Centis R, D'Ambrosio L, et al. Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis. Eur Respir J 2012; 40: 1430-1442.
29. Lee M, Lee J, Carroll MW, et al. Linezolid for treatment of chronic extensively drug-resistant tuberculosis. N Engl J Med 2012; 367: 1508-1518.
30. Tang S, Yao L, Hao X, et al. Efficacy, safety and tolerability of linezolid for the treatment of XDR-TB: a study in China. Eur Respir J 2014 [In press DOI: 10.1183/09031936.00035114].
31. De Lorenzo S, Alffenaar JW, Sotgiu G, et al. Efficacy and safety of meropenem-clavulanate added to linezolidcontaining regimens in the treatment of MDR-/XDR-TB. Eur Respir J 2013; 41: 1386-1392.
32. World Health Organization. Policy Framework for Implementing New Tuberculosis Diagnostics: March 2010. www.who.int/tb/laboratory/whopolicyframework-rev-june2011.pdf Date last accessed: July 2, 2014.
33. Weyer K, Carai S, Nunn P. Viewpoint TB diagnostics: what does the world really need?J Infect Dis 2011; 204: Suppl. 4, S1196-S1202.
34. World Health Organization. The EXPAND-TB Project Progress and Impact Brief. 2014. www.who.int/campaigns/tb-day/2014/tb-brochure.pdf Date last accessed: July 2, 2014.
35. European Centre for Disease Prevention and Control. Masterin the Basics of TB Control. www.ecdc.europa.eu/en/publications/Publications/1105-TER-Basics-TB-control.pdf